DC
CLVS

Deere & Company’s Clovis Oncology, Inc. CLVS Stock Holding History

Deere & Company’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-8,695
Closed -$582K – 1086
2013
Q2 		$582K Buy
+8,695
New +$391K 0.04% 551

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deere & Company's CLVS Position: Q3 2013 in Review

Deere & Company sold out of Clovis Oncology, Inc. (CLVS) in Q3 2013, closing a stake of 8,695 shares — an estimated $582K sold.

Deere & Company first reported a position in CLVS in Q2 2013 and held it in 1 quarter. The position peaked at $582K in Q2 2013. 116 funds tracked by Wall St. Rank hold CLVS as of Q3 2013.

  • Deere & Company reported no remaining Clovis Oncology, Inc. position as of Q3 2013 after selling out during the quarter.
  • Deere & Company sold 8,695 Clovis Oncology, Inc. shares in Q3 2013, an estimated $582K.
  • Deere & Company first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 1 quarter.
  • Deere & Company's Clovis Oncology, Inc. position peaked at $582K in Q2 2013.
  • 116 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2013.

Based on Deere & Company's 13F filing for Q3 2013, filed 12 Nov 2013.